HomeCompareJMOSX vs JNJ

JMOSX vs JNJ: Dividend Comparison 2026

JMOSX yields 5.75% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JMOSX wins by $9.2K in total portfolio value
10 years
JMOSX
JMOSX
● Live price
5.75%
Share price
$12.86
Annual div
$0.74
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.2K
Annual income
$830.78
Full JMOSX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — JMOSX vs JNJ

📍 JMOSX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodJMOSXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, JMOSX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
JMOSX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JMOSX
Annual income on $10K today (after 15% tax)
$489.17/yr
After 10yr DRIP, annual income (after tax)
$706.16/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JMOSX beats the other by $2.55/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JMOSX + JNJ for your $10,000?

JMOSX: 50%JNJ: 50%
100% JNJ50/50100% JMOSX
Portfolio after 10yr
$24.6K
Annual income
$829.28/yr
Blended yield
3.37%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

JMOSX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JMOSX buys
0
JNJ buys
0
No recent congressional trades found for JMOSX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricJMOSXJNJ
Forward yield5.75%3.36%
Annual dividend / share$0.74$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$29.2K$20.0K
Annual income after 10y$830.78$827.78
Total dividends collected$7.1K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: JMOSX vs JNJ ($10,000, DRIP)

YearJMOSX PortfolioJMOSX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,275$575.50$10,676$355.77+$599.00JMOSX
2$12,671$606.45$11,407$389.39+$1.3KJMOSX
3$14,195$636.93$12,198$426.53+$2.0KJMOSX
4$15,856$666.86$13,056$467.62+$2.8KJMOSX
5$17,662$696.13$13,987$513.12+$3.7KJMOSX
6$19,623$724.70$14,998$563.56+$4.6KJMOSX
7$21,749$752.49$16,098$619.52+$5.7KJMOSX
8$24,051$779.46$17,295$681.69+$6.8KJMOSX
9$26,540$805.56$18,599$750.82+$7.9KJMOSX
10$29,228$830.78$20,022$827.78+$9.2KJMOSX

JMOSX vs JNJ: Complete Analysis 2026

JMOSXStock

The fund invests in other Janus Henderson mutual funds and ETFs that represent a variety of asset classes and investment styles and provide exposure to issuers that are economically tied to countries throughout the world. It will have approximately 40% to 65% of its net assets allocated to non-U.S. investments. The fund invests in a diversified portfolio of underlying funds, resulting in an allocation of the fund’s investments that normally provides exposure to equity investments, fixed-income securities, money market instruments and, if available, alternative investments.

Full JMOSX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this JMOSX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JMOSX vs SCHDJMOSX vs JEPIJMOSX vs OJMOSX vs KOJMOSX vs MAINJMOSX vs ABBVJMOSX vs MRKJMOSX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.